Cardiovascular Disease

The National Lipid Association recommends all adults measure their lipoprotein (a) at least once in a lifetime to help assess cardiovascular risk

Recent findings from scientists at St. Jude Children’s Research Hospital are showing promise for assessing cardiomyopathy risk in childhood cancer survivors

To capture new demand, clinical labs should note advancing technology and rising disease mortality

The new test will allow clinicians to identify individuals at risk of a life-threatening genetic heart arrhythmia

Lp(a), is emerging as an important, yet under-recognized, potential risk factor for cardiovascular disease, a major public health issue

The paper analyzes current understanding of genetics in atrial fibrillation and recommends screening for genetic heart disease in early-onset cases

Trial reveals the need for more accurate screening in Black people and cisgender women

Some 48 proteins, 43 metabolites, age, sex, and systolic blood pressure were associated with the risk of first heart attack

The six blood biomarkers improved predictions about arterial inflammation—an indicator of cardiovascular risk

These biomarkers have the potential to change clinical practice to better predict cardiovascular risk